Iradimed IRMD
NASDAQ IRMD
$85.40 +0.10 (+0.12%)
At close: Oct 2, 2026 · 4:00 PM EDT

Iradimed (IRMD) Gains from Sales and Divestitures (2021 - 2025)

Updated

Iradimed's Gains from Sales and Divestitures was -$2,848 in Q4 2025, compared with -$128.00 a year earlier.

Analysis

Iradimed (IRMD) Gains from Sales and Divestitures (2021 - 2025) Analysis & Trends

For FY2025, Gains from Sales and Divestitures at Iradimed came in at -$37,000.

  • In earlier years, Gains from Sales and Divestitures was -$4,000 in FY2024, -$12,537 in FY2023, $1,741 in FY2022 and -$5,544 in FY2021.
  • Quarterly Gains from Sales and Divestitures has moved between -$33,152 (Q3 2025) and $704,687 (Q3 2021) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn
10 Iradimed 1.09 Bn 868.85 Mn 15.16 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -2,848.00
Sep 30, 2025 -33,152.00
Dec 31, 2024 -128.00
Jun 30, 2024 -3,665.00
Mar 31, 2024 -207.00
Dec 31, 2023 -2.00
Sep 30, 2023 -8,683.00
Dec 31, 2022 -1,259.00
Sep 30, 2022 -1,894.00
Mar 31, 2022 4,894.00
Dec 31, 2021 -4,478.00
Sep 30, 2021 704,687.00
API Access

Iradimed Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=IRMD&period=max&api_key=YOUR_API_KEY